luspatercept
bms,merck
['leusm', '#389', 'leukemia', 'lusp', 'lymphoma', 'medalist trial', 'mds', 'celgene']
congress | #ash22 presents results from a retrospective analysis where &gt;90% of patients with lr-mds and low transfusion at baseline burden achieved transfusion independence within the first 24 weeks of luspatercept treatment. #mds #leusm 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm